Tyto Stethoscope
Tyto Care Ltd. • Cardiovascular • 10/19/2016
Device Purpose
The Tyto Stethoscope is an electronic auscultation device designed for both professional and lay use, enabling remote examination of heart, lung, and other bodily sounds via IP network transmission. It utilizes a piezo sensor for sound detection and incorporates Bell and Diaphragm filters, operating through mobile app integration and a server platform for either store-and-forward or real-time clinical assessment.
Summary
The Tyto Stethoscope is an electronic device designed for auscultation, enabling the capture and transmission of bodily sounds such as those from the heart and lungs. It caters to both professional clinicians in clinical settings and lay users in non-clinical environments, facilitating remote medical consultations. The device supports four examination types: Heart, Lungs, Heart Rate, and an Audio mode restricted to clinicians. Its utility is extended through two operational modes: a store-and-forward flow, allowing users to record and send data at their convenience, and an on-line exam flow for real-time consultations when a clinician is concurrently available. The system operates using four main components: the Tyto Stethoscope itself (comprising a Stethoscope Tip and a Base Unit with proprietary software), a user-provided mobile device running the TytoCare App, the Tyto Server platform (on user-provided server hardware with proprietary software), and a clinician's receiving platform (e.g., a PC with proprietary Clinician App). Scientifically, the device detects auscultation sounds using a piezo sensor. It employs Bell and Diaphragm filters and covers a comparable acoustic frequency range to predicate devices. Data, including heart rate, is transmitted over an IP network, allowing clinicians to remotely assess patient sounds. Performance testing confirmed its functionality in areas like stethoscope performance, heart rate accuracy, wireless coexistence, software validation, electrical safety, and biocompatibility.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the diagnostic accuracy of remotely transmitted auscultation sounds via the Tyto Stethoscope compare to traditional, in-person auscultation across diverse patient populations and acoustic environments?; What are the specific data security and privacy measures implemented within the Tyto Server platform and app ecosystem, particularly concerning the transmission and storage of sensitive patient auscultation data over IP networks?; What was the methodology and outcome of the usability study, particularly regarding the ease of use for lay users in non-clinical environments and the potential for misinterpretation or incorrect application of the device?; How does the device's performance, specifically sound quality and heart rate accuracy, vary with different types of mobile devices and network conditions (e.g., bandwidth, latency) used in the system?; Are there any specific clinical scenarios or patient conditions where the Tyto Stethoscope is particularly advantageous or, conversely, where its use might be limited compared to standard clinical stethoscopes?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SaaSBOM, HBOM, OBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Not detected in AI-generated device summary: SBOM, ML-BOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly